REFERENCES
- Anderson, C.E., & Loomis, G.A. (2003). Recognition and prevention of inhalant abuse. American Family Physician, 68(5), 869–874.
- Audo, I., El Sanharawi, M., Vignal-Clermont, C., Villa, A., Morin, A., Conrath, J., … Paques, M. (2011). Foveal damage in habitual poppers users. Archives of Ophthalmology, 129(6), 703–708.
- Cheitlin, M.D., Hutter, A. M.Jr., Brindis, R. G., Ganz, P., Kaul, S., Russell, R. O.Jr., & Zusman, R. M., (1999). Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation, 99(1), 168–177.
- Moncada, S., & Higgs, A. (1993). The L-arginine-nitric oxide pathway. New England Journal of Medicine, 329(27), 2002–2012.
- Romanelli, F., Smith, K. M., Thornton, A. C., & Pomeroy, C. (2004). Poppers: Epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy, 24(1), 69–78.
- Tormoehlen, L.M., Tekulve, K.J., & Nanagas, K.A. (2014). Hydrocarbon toxicity: A review. Clinical Toxicology (Philadelphia), 52(5), 479–489.
- Vandenbroucke, J.P., & Pardoel, V.P. (1989). An autopsy of epidemiologic methods: The case of “poppers” in the early epidemic of the acquired immunodeficiency syndrome (AIDS). American Journal of Epidemiology, 129(3), 455–457.